News

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...
Republican leader Donald Trump issued the brutal remark whilst discussing diabetes medications used for weight loss ...
IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But Weight ...
Wegovy and Mounjaro have been taking the world by storm for their unprecedented ability to help people shed weight. New ...
A leading obesity doctor has said a new trial of weight loss drugs Mounjaro and Wegovy may lead advertisers to reconsider their prices.
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
Two blockbuster weight-loss drugs just went head-to-head — and the results are stunning. In a major new trial, Mounjaro ...
The popularity of expensive weight-loss medications and other prescription drugs along with higher hospital costs are driving ...
Tirzepatide is a weight loss drug for adults with obesity or with overweight who also have weight-related medical problems, as Zepbound in the US and Mounjaro in some countries outside of the US ...
In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...
Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...
Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...